Adaptimmune Therapeutics plc (ADAP) Logo

    Adaptimmune Therapeutics plc (ADAP) symbol, logo with name and high resolution download options.

    Adaptimmune Therapeutics plc (ADAP) logo

    Sector

    Healthcare

    Industry

    Biotechnology

    Ticker

    ADAP

    About Adaptimmune Therapeutics plc (ADAP)

    Adaptimmune Therapeutics plc, a commercial-stage biopharmaceutical company, provides novel cell therapies primarily to cancer patients in the United States and the United Kingdom. It develops TECELRA ((famitresgene autoleucel or afami-cel), a genetically modified autologous T-cell immunotherapy for the treatment of adults with unresectable or metastatic synovial sarcoma; Lete-cel for the treatment synovial sarcoma and myxoid liposarcoma; and ADP-5701, which is in Phase 1 clinical trial for the treatment of head and neck cancer. The company also focuses on the development of T-cell therapies directed to PRAME (ADP-600) and CD70 (ADP-520). It has strategic collaboration with Galapagos to clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel produced on Galapagos’ decentralized manufacturing platform (ADP-5701) in patients with head and neck cancer; collaboration and license agreement with Noile-Immune Biotech, Inc. and strategic alliance agreement with the MD Anderson Cancer Center. Adaptimmune Therapeutics plc was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

    ISIN: US00653A1079
    Ticker: 473A
    Ticker: 473A.DU
    Ticker: 473A.F
    Ticker: 473A.MU
    Ticker: 473A.SW
    Ticker: A14SUX
    Ticker: ADAP
    Browse more company logos →

    Get Adaptimmune Therapeutics plc (ADAP) Logo via API

    Integrate this logo into your application with a single API call

    GET https://api.logostream.dev/stocks/symbol/ADAP?key=YOUR_API_KEY&variant=icon

    Why Use Our Stock Logo API?

    Fast Delivery

    <100ms response time via global CDN

    Enterprise-Ready

    99.99% uptime SLA with GDPR compliance

    Multiple Formats

    SVG, PNG, WebP - scalable to any size

    400k+ Logos

    Stocks, ETFs, Crypto, Banks, and more

    Where to Use Stock Logos

    Trading Platforms

    Real-time stock displays with instant logo loading

    Portfolio Apps

    Visualize holdings with recognizable brand logos

    Financial Dashboards

    Enhance market data with company branding

    News & Research

    Illustrate articles with accurate company logos

    Frequently Asked Questions

    Use our Stock Logo API with the ticker symbol ADAP. Make a GET request to https://api.logostream.dev/stocks/symbol/ADAP?key=YOUR_API_KEY to receive the logo. You can also specify format (SVG, PNG, WebP) and size parameters.

    The Adaptimmune Therapeutics plc (ADAP) logo is available in SVG, PNG, WebP, and JPG formats. SVG is recommended for scalability. Use the format parameter to specify your preferred format, e.g., ?format=svg or ?format=png.

    With a logostream API subscription, you can use logos for display purposes in financial applications, trading platforms, dashboards, and portfolio trackers. The logos are provided for informational and display purposes within your application.

    Simply embed the API URL as an image source in your application. For example: <img src="https://api.logostream.dev/stocks/symbol/ADAP?key=YOUR_API_KEY" />. The API returns optimized images with proper caching headers for fast loading.

    The Adaptimmune Therapeutics plc (ADAP) logo is a trademark of its respective owner. logostream is not affiliated with Adaptimmune Therapeutics plc (ADAP) and provides this logo for identification purposes only. Logo usage is subject to the trademark holder's brand guidelines -- see our Terms of Service for the attribution requirements that apply to the Logo API.

    Need Stock Logos for Your Application?

    Access 380,000+ company logos via our simple REST API. Perfect for trading platforms, portfolio apps, and financial dashboards.